Arizona State Retirement System’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$564K Buy
16,656
+4,281
+35% +$141K ﹤0.01% 1481
2026
Q1
$396K Sell
12,375
-358
-3% -$11.7K ﹤0.01% 1587
2025
Q4
$447K Sell
12,733
-518
-4% -$18.9K ﹤0.01% 1547
2025
Q3
$377K Buy
13,251
+483
+4% +$11.6K ﹤0.01% 1669
2025
Q2
$231K Buy
12,768
+2,282
+22% +$41.6K ﹤0.01% 1848
2025
Q1
$215K Buy
+10,486
New +$233K ﹤0.01% 1857

Other funds holding NAMS

Arizona State Retirement System's NAMS Position: Q2 2026 in Review

Arizona State Retirement System increased its NewAmsterdam Pharma (NAMS) stake by 35% in Q2 2026, buying an estimated $141K and bringing the position to 16,656 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Arizona State Retirement System first reported a position in NAMS in Q1 2025 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Arizona State Retirement System held 16,656 shares of NewAmsterdam Pharma worth $564K as of Q2 2026.
  • Arizona State Retirement System bought 4,281 NewAmsterdam Pharma shares in Q2 2026, an estimated $141K.
  • NewAmsterdam Pharma made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1481 holding.
  • Arizona State Retirement System first reported a position in NewAmsterdam Pharma in Q1 2025 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.